Fungi · Scientific monograph
Agaricus blazei
Royal Sun Agaricus / ABM
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Immunological Research, Glucose & Metabolic Research, Cellular & Immune Studies
Research overview
Historical use
Native to the Piedade region of Brazil, where it is known as 'Cogumelo do Sol' (mushroom of the sun) or 'Cogumelo de Deus' (mushroom of God). Introduced to Japan in the 1960s, where it became popular after researchers noted low rates of cancer and infections in the Brazilian community that consumed it regularly.
Modern research context
Studied primarily for immunomodulation and anti-tumour activity [1][4]. A Norwegian randomised clinical trial with AndoSan preparation demonstrated reduced inflammatory cytokine markers (TNF-α, IL-6) in blood donors [2]. Reduced inflammatory mediators were also observed in elderly women in a separate randomised trial [3]. Chemical composition analysis confirms beta-glucans and ergosterol as the primary bioactives driving immunomodulatory effects [4][5].
Adverse effects
GI upset (nausea, diarrhoea). Rare hepatotoxicity reported (case reports, likely idiosyncratic). Eosinophilia reported in one RCT. Hypoglycaemia risk.
Contraindications
Anticoagulants — potential additive effect. Antidiabetic drugs — additive hypoglycaemia risk. Pre-existing liver disease — use with caution given case reports of hepatotoxicity.
Clinical and phytochemical data
Used part
Fruiting body
Primary active compounds
Beta-1,3/1,6-D-glucans (high content, up to 40% dry weight)
Polysaccharides (AbPS)
Ergosterol
Blazein (steroid compound)
Agaritine (hydrazine derivative — potentially genotoxic)
Mechanism of action
Beta-glucans activate macrophages and NK cells via Dectin-1; upregulate Th1 cytokines (IL-12, IFN-γ, TNF-α). Anti-tumour mechanisms include direct cytotoxicity via induction of apoptosis (caspase-3 pathway) and anti-angiogenic effects. Antidiabetic mechanism involves PPAR-γ activation and improved insulin receptor signalling. Agaritine is a potentially carcinogenic hydrazine compound degraded by cooking.
Pharmacokinetics
Absorption
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Beta-glucan fractions partially absorbed; primarily active at GALT. Detailed human PK data not available.
Distribution
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Beta-glucan fractions concentrate at gut-associated lymphoid tissue (GALT), spleen, and mesenteric lymph nodes; limited systemic distribution. Blazein (steroid compound) distributes broadly due to lipophilicity; plasma protein binding not established in humans. No quantitative human tissue distribution studies available.
Metabolism
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Hepatic metabolism of absorbed fractions. Agaritine hydrolysed by gut bacteria and enzymes; cooking significantly reduces agaritine content.
Excretion
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Primarily fecal for polysaccharides; renal for smaller metabolites.
Safety and interactions
Drug interactions
Lack of clinical studies prevents interaction grading. Unknown safety profile with concomitant drug use.
Toxicity
LD50 >5 g/kg (oral, rodents). Rare cases of hepatotoxicity in humans (likely idiosyncratic). Agaritine content: raw mushroom contains up to 500 mg/kg; cooking, drying, or storage reduces this substantially. Long-term human clinical data on agaritine exposure are insufficient to fully characterise the risk.
Special precautions
Pregnancy
Insufficient safety data. Presence of agaritine (potentially genotoxic hydrazine derivative) warrants avoidance during pregnancy.
Lactation
Insufficient data. Avoid concentrated supplemental preparations during breastfeeding.
Hepatic impairment
Case reports of hepatotoxicity exist; avoid in patients with hepatic disease or monitor liver enzymes carefully.
Renal impairment
No specific data available. Standard monitoring recommended.
Sources and references
- [1] - Hetland G., "Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract.", Nutrients, 2020, PMID: 32397163
- [2] - Mahmood F., "Agaricus blazei-Based Mushroom Extract Supplementation to Birch Allergic Blood Donors: A Randomized and Double-Blinded Crossover Trial.", Nutrients, 2019, PMID: 31581605
- [3] - Lima CU., "Agaricus blazei Murrill and inflammatory mediators in elderly women: a randomized clinical study.", Scand J Immunol, 2012, PMID: 22010847
- [4] - Huang K., "Critical review on chemical compositions and health-promoting effects of mushroom Agaricus.", Curr Res Food Sci, 2022, PMID: 36387602
- [5] - da Silva de Souza AC., "Agaricus blazei Bioactive Compounds and their Effects on Human Health: Benefits and Controversies.", Curr Pharm Des, 2017, PMID: 28103773